Experts on vaccines, infectious diseases and global health describe the latest stage of the pandemic.
Texas A&M virologist Benjamin Neuman discusses how the coronavirus variant could affect the U.S.
Any student who has not tested positive for SARS-CoV-2 and has not received a vaccine might be eligible to participate.
A panel of experts recently discussed COVID-19, vaccines, and predictions for future variants during a virtual event.
A single case led to only mild symptoms. The variant is named BV-1 for its Brazos Valley origin.
The collaborative study shows enzyme inhibitor K777 is effective in combatting SARS-CoV-2.
Student volunteers will participate in a clinical trial to determine if vaccinated people can still spread the virus.
Texas A&M experts say ending the pandemic depends on extensive vaccinations. Eroding confidence in vaccines could sink the effort.
Texas A&M College of Nursing students are gaining vital experience while administering vaccines at the Brazos County hub.
The world will need to plan ahead and develop systems for fighting the next outbreak, Texas A&M experts say.